Asset Comparison and Correlation
|GlaxoSmithKline plc vs Merck & Co. Inc.|
Considering 30-days investment horizon, GlaxoSmithKline plc is expected to generate 0.68 times more return on investment than Merck. However, GlaxoSmithKline plc is 1.46 times less risky than Merck. It trades about 0.21 of its potential returns per unit of risk. Merck Co Inc is currently generating about -0.18 per unit of risk. If you would invest 5,112 in GlaxoSmithKline plc on April 20, 2013 and sell it today you would earn a total of 110.00 from holding GlaxoSmithKline plc or generate 2.15% return on investment over 30 days.
90% of all equities and portfolios perform better than GlaxoSmithKline plc. Compared with the overall equity markets, risk-adjusted returns on investments in GlaxoSmithKline plc are ranked lower than 10 (%) of all global equities and portfolios over the last 30 days.
Match ups for GlaxoSmithKl
Over the last 30 days Merck Co Inc has generated negative risk-adjusted returns adding no value to investors with long positions.
Match ups for Merck